Cloud Banner

Medical Devices

Image

North America Flow Cytometry Market – Industry Trends and Forecast to 2030

  • Medical Devices
  • Published Report
  • Apr 2023
  • North America
  • 350 Pages
  • No of Tables: 89
  • No of Figures: 39

North America Flow Cytometry Market – Industry Trends and Forecast to 2030

Market Size in USD Billion

CAGR - 12.6% Diagram

Diagram Forecast Period 2022–2030
Diagram Market Size (Base Year) USD 2725.01 Million
Diagram Market Size (Forecast Year) USD 6984.82 Million
Diagram CAGR 12.6%

North America Flow Cytometry Market, By Product (Flow Cytometry Instruments, Reagents and Consumables, Software, Accessories, and Services), Technology (Cell-Based Flow Cytometry and Bead-Based Flow Cytometry), Application (Research Applications, Clinical Applications, and Industrial Applications), End User (Academic & Research Institutes, Hospitals, Pharmaceutical & Biotechnology Companies, Clinical Testing Laboratories, Blood Bank, and Others), Distribution Channel (Direct Tenders, and Retail Sales) - Industry Trends and Forecast to 2030.

Flow Cytometry Market

North America Flow Cytometry Market Analysis and Insights

North America flow cytometry market is driven by the factors such as the increasing prevalence of chronic diseases, growing demand for new technologies in the flow cytometry market, which enhances its demand, as well as increasing investment in research and development, which leads to market growth. Currently, healthcare expenditure has increased across developed and emerging countries which is expected to create a competitive advantage for manufacturers to develop new and innovative flow cytometry markets. However, the high cost of flow cytometry instruments is anticipated to restrain the growth of the North America flow cytometry market.

Flow Cytometry Market

Flow Cytometry Market

North America flow cytometry market report provides details of market share, new developments, and product pipeline analysis, the impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario, contact us for an analyst brief, and our team will help you create a revenue impact solution to achieve your desired goal. The scalability and business expansion of the retail units in the developing countries of various regions and partnership with suppliers for the safe distribution of machine and drug products are the major drivers which propelled the demand of the market in the forecast period.

North America flow cytometry market is expected to gain market growth in the forecast period of 2023 to 2030. Data Bridge Market Research analyses that the market is growing with a CAGR of 12.6% in the forecast period of 2023 to 2030 and is expected to reach USD 6,984.82 Million by 2030 from USD 2,725.01 Million in 2022.

Report Metric

Details

Forecast Period

2023 to 2030

Base Year

2022

Historic Years

2021 (Customizable to 2015-2020)

Quantitative Units

Revenue in USD Million

Segments Covered

By Product (Flow Cytometry Instruments, Reagents and Consumables, Software, Accessories, and Services), Technology (Cell-Based Flow Cytometry and Bead-Based Flow Cytometry), Application (Research Applications, Clinical Applications, and Industrial Applications), End User (Academic & Research Institutes, Hospitals, Pharmaceutical & Biotechnology Companies, Clinical Testing Laboratories, Blood Bank, and Others), Distribution Channel (Direct Tenders, and Retail Sales)

Countries Covered

U.S., Canada, and Mexico

Market Players Covered

Thermo Fisher Scientific Inc. (U.S.), BD(U.S.), Agilent Technologies, Inc. (U.S.), Nexcelom Bioscience LLC (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Sysmex Corporation(Japan), Miltenyi Biotec (Germany), Coherent Corp. (U.S.), Beckman Coulter, Inc. (A subsidiary of Danaher Corporation) (U.S.), Cytek Biosciences (U.S.), BIOMÉRIEUX (France), Q2 Solutions (a Subsidiary of IQVIA) (U.S.), Cytonome/ST, LLC (U.S.), Merck KGaA (Germany), Sony Biotechnology Inc. (U.S.), Cell Signaling Technology, Inc. (U.S.), NanoCellect Biomedical (U.S.), Apogee Flow Systems Ltd. (U.K.), Bay bioscience Co., Ltd. (Japan), Stratedigm, Inc., BioLegend, Inc. (U.S.), NeoGenomics Laboratories(U.S.), Enzo Biochem Inc. (U.S.), Union Biometrica, Inc. (U.S.), BennuBio Inc. (U.S.), ORLFO Technologies(U.S.), Elabscience Biotechnology Inc. (U.S.), Takara Bio Inc. (Japan), among others

Market Definition

Flow cytometry is a key process for screening cells from a heterologous cell mixture used in cell sorting, counting, protein regeneration, and engineering. The analysis of cell surface and intracellular molecule expression, the characterization and definition of various cell types in a heterogeneous cell population, the evaluation of the purity of isolated subpopulations, and the measurement of cell size and volume are all common uses for flow cytometry. It enables the simultaneous examination of multiple parameters for a single cell. A flow cytometer uses lasers to produce light, which is subsequently dispersed by the sample's cells, recorded by detectors, and converted into signals for analysis and measurement.

The increasing innovations and technologies and rising number of players in the market, and novel product launches are also propelling the growth of the North America flow cytometry market.

North America Flow Cytometry Market Dynamics

Drivers

  • Rising prevalence of chronic diseases

These increasing prevalence and incidences of chronic diseases are likely to drive market growth by focusing on cytometry devices. The increasing incidences of diseases lead to an increase in the North America market as many companies are investing in research and development. This resulted in the enormous lead in demand for advancements to diagnose the disease through quick and accurate techniques.

For instance,

  • In January 2021, according to a World Health Organization report, cancer became the major cause of death in 2020, with 10 million in approximation, where often cases were of breast cancer (2.26 million), lung (2.21 million), colon and rectum (1.93 million); prostate (1.41 million), skin (1.20 million) and stomach (1.09 million)

Therefore, this is raising the demand for North America flow cytometry market.

  • Increasing application of cytometry instruments

Technological developments in cytometry instruments are rising by combining several new techniques to provide high resolution and sensitivity to quantify new entities of cells.

The immunophenotypic analysis is important not only for the initial diagnosis and categorization of acute leukemia, chronic lymphoproliferative disorders, and malignant lymphomas but also for their treatment. Flow cytometry can be used as a sensitive assay to track patients' improvement after chemotherapy or transplantation and detect minimal residual illness (MRD).

For instance,

  • In March 2021, Beckman Coulter introduced a CytoFLEX platform that can easily provide multicolor applications, resulting in broadening the technology's laser and color options and causing more technical advancements in this field. The company combined many technologies in CytoFLEX to produce high resolution and sensitivity
  • In January 2022, Becton, Dickinson and Company, a North America medical technology company, announced that a study conducted in collaboration with the European Molecular Biology Laboratory (EMBL) and published the new BD innovation in flow cytometry that adds fluorescence imaging and image-based deaccessioning to sort individual cells at exceptionally high speed, based on the visual details of each cell rather than the type or quantity of biomarkers present. The novel method has the potential to revolutionize immunology, cell biology, and genomics research, as well as enable the development of new cell-based therapeutics

 Thus, this is expected to act as a driver for the growth of the North America flow cytometry market.

Opportunities

  • Increase in adoption of flow cytometry techniques in research and academia

Approval of new technologies provides a new set-off venture in the market. A new mechanism of action is needed to drive the market as it provides innovation in the process by targeting with a different mechanism. It leads to the need for a new product launch in the market.

For instance,

  • In March 2021, Beckman Coulter introduced a CytoFLEX platform that can easily provide multicolor applications, resulting in broadening the technology's laser and color options and causing more technical advancements in this field. The company combined many technologies in CytoFLEX to produce high resolution and sensitivity

Hence, flow cytometry provides quick and accurate techniques for diagnosing diseases. The growing demand for advanced diagnostic results for clinical purposes may propel the market's rapid growth.

  • Rising healthcare expenditure

The expense of money used by a country on its healthcare and its growth rate over time is inclined by a wide variety of economic and social factors, including the financing arrangements and structure of the organization of the health system. In particular, there is a strong association between the complete income level of a country and how much the population of that country spends on health care.

Also, the strategic initiatives taken by key market players will provide structural integrity and future opportunities for the North America flow cytometry market in the forecast period of 2023-2030.

Restraints/Challenges

  • High cost of flow cytometry instruments

Flow cytometers come in a variety of shapes and sizes, although benchtop instruments are the most common. They offer optimal data analysis, the convenience of use, and upgrades and options for various systems, all of which are intended to solve customized separations, cell/particle sorting, exploratory cell analysis, and other issues. All flow cytometers feature three common components – fluids, optics, and electronics/informatics.

Flow cytometers are very expensive especially considering the cost associated with repair and maintenance.

COVID-19 Impact on the North America Flow Cytometry Market

COVID-19 has positively affected the market due to disease diagnosis and research purposes, which raises the demand for flow cytometry during this period.

Recent Development

  • In January 2022, Sony Biotechnology, Inc. presented a novel closed cell isolation system CGX10 for use in GMP-compliant cell sorting applications. With the initiative, new growth opportunities were hoped for the company. Such advances in technology will lead to cost-effectiveness, greater accuracy and portability and are likely to create future growth opportunities.

North America Flow Cytometry Market Scope

The North America flow cytometry market is segmented into product, technology, application, end user, and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to make strategic decisions to identify core market applications.

Product

  • Reagents and consumables
  • Flow cytometry instruments
  • Accessories
  • Services
  • Software

On the basis of product, the North America flow cytometry market is segmented into flow cytometry instruments, reagents and consumables, software, accessories, and services.

Technology

  • Cell-based flow cytometry
  • Bead-based flow cytometry

On the basis of technology, the North America flow cytometry market is segmented into cell-based flow cytometry and bead-based flow cytometry.

Application

  • Research applications
  • Clinical applications
  • Industrial applications

On the basis of application, the North America flow cytometry market is segmented into research applications, clinical applications, and industrial applications.

End User

  • Pharmaceuticals & biotechnology companies
  • Academic & Research institutes
  • Hospitals
  • Clinical testing laboratories
  • Blood bank
  • Others

On the basis of end users, the North America flow cytometry market is segmented into academic & research institutes, hospitals, pharmaceutical & biotechnology companies, clinical testing laboratories, blood bank, and others.

Distribution Channel

  • Retail sales
  • Direct tenders

On the basis of distribution channel, the North America flow cytometry market is segmented into retail sales and direct tenders.

Flow Cytometry Market

North America Flow Cytometry Market Regional Analysis/Insights

The North America flow cytometry market is analyzed, and market size insights and trends are provided by country, product, technology, application, end user, and distribution channel referenced above.

The U.S. is the major dominating country in the market due to the surging incidence rate of diseases such as cancer and HIV amongst the population in this country, which is boosting the demand for flow cytometry for diagnostic applications. And they are dominating the flow cytometry market in terms of market share and market revenue and will continue to flourish dominance during the forecast period.

The country section of the report also provides individual market impacting factors and changes in regulations in the market that impact the current and future trends of the market. Data points, such as new and replacement sales, country demographics, disease epidemiology, and import-export tariffs, are some of the major pointers used to forecast the market scenario for individual countries. In addition, the presence and availability of North America brands and the challenges faced due to high competition from local and domestic brands, and the impact of sales channels are considered while providing forecast analysis of the country data.

Competitive Landscape and North America Flow Cytometry Market Share Analysis

The North America flow cytometry market competitive landscape provides details about the competitors. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, North America presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, and application dominance. The above data points provided are only related to the company's focus on the flow cytometry market.

Some of the major players operating in the flow cytometry market are Thermo Fisher Scientific Inc., BD, Agilent Technologies, Inc., Nexcelom Bioscience LLC, Bio-Rad Laboratories, Inc., Sysmex Corporation, Miltenyi Biotec, Coherent Corp., Beckman Coulter, Inc. (A subsidiary of Danaher Corporation), Cytek Biosciences, bioMérieux SA, Q2 Solutions (a Subsidiary of IQVIA), Cytonome/ST, LLC, Merck KGaA, Sony Biotechnology Inc., Cell Signaling Technology, Inc., NanoCellect Biomedical, Apogee Flow Systems Ltd., Bay bioscience Co., Ltd., Stratedigm, Inc., BioLegend, Inc., NeoGenomics Laboratories, Enzo Biochem Inc., Union Biometrica, Inc., BennuBio Inc., ORLFO Technologies, Elabscience Biotechnology Inc., Takara Bio Inc., among others.


SKU-

TABLE 1 NORTH AMERICA FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 2 NORTH AMERICA REAGENTS AND CONSUMABLES IN FLOW CYTOMETRY MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 3 NORTH AMERICA REAGENTS AND CONSUMABLES IN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 4 NORTH AMERICA FLOW CYTOMETRY INSTRUMENTS IN FLOW CYTOMETRY MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 5 NORTH AMERICA FLOW CYTOMETRY INSTRUMENTS IN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 6 NORTH AMERICA CELL ANALYZERS IN FLOW CYTOMETRY MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 7 NORTH AMERICA CELL ANALYZERS IN FLOW CYTOMETRY MARKET, BY MODALITY, 2021-2030 (USD MILLION)

TABLE 8 NORTH AMERICA CELL SORTERS IN FLOW CYTOMETRY MARKET, BY MODALITY, 2021-2030 (USD MILLION)

TABLE 9 NORTH AMERICA ACCESSORIES IN FLOW CYTOMETRY MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 10 NORTH AMERICA ACCESSORIES IN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 11 NORTH AMERICA SERVICES IN FLOW CYTOMETRY MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 12 NORTH AMERICA SOFTWARE IN FLOW CYTOMETRY MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 13 NORTH AMERICA FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)

TABLE 14 NORTH AMERICA CELL-BASED FLOW CYTOMETRY IN FLOW CYTOMETRY MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 15 NORTH AMERICA BEAD-BASED FLOW CYTOMETRY IN FLOW CYTOMETRY MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 16 NORTH AMERICA FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 17 NORTH AMERICA RESEARCH APPLICATIONS IN FLOW CYTOMETRY MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 18 NORTH AMERICA RESEARCH APPLICATIONS IN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 19 NORTH AMERICA PHARMACEUTICAL AND BIOTECHNOLOGY IN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 20 NORTH AMERICA CLINICAL APPLICATIONS IN FLOW CYTOMETRY MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 21 NORTH AMERICA CLINICAL APPLICATIONS IN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 22 NORTH AMERICA INDUSTRIAL APPLICATIONS IN FLOW CYTOMETRY MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 23 NORTH AMERICA FLOW CYTOMETRY MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 24 NORTH AMERICA PHARMACEUTICALS & BIOTECHNOLOGY COMPANIES IN FLOW CYTOMETRY MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 25 NORTH AMERICA ACADEMIC & RESEARCH INSTITUTES IN FLOW CYTOMETRY MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 26 NORTH AMERICA HOSPITALS IN FLOW CYTOMETRY MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 27 NORTH AMERICA CLINICAL TESTING LABORATORIES IN FLOW CYTOMETRY MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 28 NORTH AMERICA BLOOD BANK IN FLOW CYTOMETRY MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 29 NORTH AMERICA OTHERS IN FLOW CYTOMETRY MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 30 NORTH AMERICA FLOW CYTOMETRY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 31 NORTH AMERICA RETAIL SALES IN FLOW CYTOMETRY MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 32 NORTH AMERICA DIRECT TENDERS IN FLOW CYTOMETRY MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 33 NORTH AMERICA FLOW CYTOMETRY MARKET, BY COUNTRY, 2021-2030 (USD MILLION)

TABLE 34 NORTH AMERICA FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 35 NORTH AMERICA REAGENTS AND CONSUMABLES IN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 36 NORTH AMERICA FLOW CYTOMETRY INSTRUMENTS IN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 37 NORTH AMERICA CELL ANALYZERS IN FLOW CYTOMETRY MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 38 NORTH AMERICA CELL ANALYZERS IN FLOW CYTOMETRY MARKET, BY MODALITY, 2021-2030 (USD MILLION)

TABLE 39 NORTH AMERICA CELL SORTERS IN FLOW CYTOMETRY MARKET, BY MODALITY, 2021-2030 (USD MILLION)

TABLE 40 NORTH AMERICA ACCESSORIES IN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 41 NORTH AMERICA FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)

TABLE 42 NORTH AMERICA FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 43 NORTH AMERICA RESEARCH APPLICATIONS IN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 44 NORTH AMERICA PHARMACEUTICAL AND BIOTECHNOLOGY IN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 45 NORTH AMERICA CLINICAL APPLICATIONS IN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 46 NORTH AMERICA FLOW CYTOMETRY MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 47 NORTH AMERICA FLOW CYTOMETRY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 48 U.S. FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 49 U.S. REAGENTS AND CONSUMABLES IN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 50 U.S. FLOW CYTOMETRY INSTRUMENTS IN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 51 U.S. CELL ANALYZERS IN FLOW CYTOMETRY MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 52 U.S. CELL ANALYZERS IN FLOW CYTOMETRY MARKET, BY MODALITY, 2021-2030 (USD MILLION)

TABLE 53 U.S. CELL SORTERS IN FLOW CYTOMETRY MARKET, BY MODALITY, 2021-2030 (USD MILLION)

TABLE 54 U.S. ACCESSORIES IN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 55 U.S. FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)

TABLE 56 U.S. FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 57 U.S. RESEARCH APPLICATIONS IN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 58 U.S. PHARMACEUTICAL AND BIOTECHNOLOGY IN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 59 U.S. CLINICAL APPLICATIONS IN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 60 U.S. FLOW CYTOMETRY MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 61 U.S. FLOW CYTOMETRY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 62 CANADA FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 63 CANADA REAGENTS AND CONSUMABLES IN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 64 CANADA FLOW CYTOMETRY INSTRUMENTS IN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 65 CANADA CELL ANALYZERS IN FLOW CYTOMETRY MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 66 CANADA CELL ANALYZERS IN FLOW CYTOMETRY MARKET, BY MODALITY, 2021-2030 (USD MILLION)

TABLE 67 CANADA CELL SORTERS IN FLOW CYTOMETRY MARKET, BY MODALITY, 2021-2030 (USD MILLION)

TABLE 68 CANADA ACCESSORIES IN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 69 CANADA FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)

TABLE 70 CANADA FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 71 CANADA RESEARCH APPLICATIONS IN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 72 CANADA PHARMACEUTICAL AND BIOTECHNOLOGY IN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 73 CANADA CLINICAL APPLICATIONS IN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 74 CANADA FLOW CYTOMETRY MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 75 CANADA FLOW CYTOMETRY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 76 MEXICO FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 77 MEXICO REAGENTS AND CONSUMABLES IN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 78 MEXICO FLOW CYTOMETRY INSTRUMENTS IN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 79 MEXICO CELL ANALYZERS IN FLOW CYTOMETRY MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 80 MEXICO CELL ANALYZERS IN FLOW CYTOMETRY MARKET, BY MODALITY, 2021-2030 (USD MILLION)

TABLE 81 MEXICO CELL SORTERS IN FLOW CYTOMETRY MARKET, BY MODALITY, 2021-2030 (USD MILLION)

TABLE 82 MEXICO ACCESSORIES IN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 83 MEXICO FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)

TABLE 84 MEXICO FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 85 MEXICO RESEARCH APPLICATIONS IN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 86 MEXICO PHARMACEUTICAL AND BIOTECHNOLOGY IN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 87 MEXICO CLINICAL APPLICATIONS IN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 88 MEXICO FLOW CYTOMETRY MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 89 MEXICO FLOW CYTOMETRY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

FREQUENTLY ASK QUESTIONS

The North America Flow Cytometry Market is projected to grow at a CAGR of 12.6% during the forecast period by 2030.
The future market value of the North America Flow Cytometry Market is expected to reach USD 6,984.82 Million by 2030.
The major players in the North America Flow Cytometry Market are Thermo Fisher Scientific Inc. (U.S.), BD(U.S.), Agilent Technologies, Inc. (U.S.), Sartorius AG (Germany), Bio-Rad Laboratories, Inc. (U.S.), Sysmex Corporation(Japan), Coherent Corp. (U.S.), etc.
The countries covered in the North America Flow Cytometry Market are U.S., Canada, and Mexico.
Free Sample Report

CHOOSE LICENCE TYPE

  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials